Brief: Ampio Reports Acceptance Of Publication On Potential Benefits Of Nebulized Ampion For Covid-19 Patients
11/05/2020 13:43
Ampio Pharmaceuticals Inc AMPE.A :
* AMPIO REPORTS ACCEPTANCE OF PUBLICATION ON POTENTIAL
BENEFITS OF
NEBULIZED AMPION FOR COVID-19 PATIENTS
Source text for Eikon: ID:nPn83nmXLa
Further company coverage: AMPE.A
Recent news on Ampio Pharmaceuticals
See all newsBrief: Ampio Announces Voluntary Delisting And SEC Deregistration
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank